and three years after treatment in a pooled analysis of Study 101 (phase I/II, NCT03375164, n=4), Study 102 (phase II, NCT03769116, n=26), and ENDEAVOR Cohort 1 (phase Ib, NCT04626674, n=20), compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback